Advances in local therapy for glioblastoma—taking the fight to the tumour

TS van Solinge, L Nieland, EA Chiocca… - Nature Reviews …, 2022 - nature.com
Despite advances in neurosurgery, chemotherapy and radiotherapy, glioblastoma remains
one of the most treatment-resistant CNS malignancies, and the tumour inevitably recurs. The …

[HTML][HTML] Glioblastoma: overview of disease and treatment

ME Davis - Clinical journal of oncology nursing, 2016 - ncbi.nlm.nih.gov
Background Glioblastoma (GBM) is the most common and aggressive malignant brain tumor
in adults. Current treatment options at diagnosis are multimodal and include surgical …

Clinical practice guidelines for the management of adult diffuse gliomas

T Jiang, DH Nam, Z Ram, W Poon, J Wang… - Cancer letters, 2021 - Elsevier
To follow the revision of the fourth edition of WHO classification and the recent progress on
the management of diffuse gliomas, the joint guideline committee of Chinese Glioma …

Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly …

AM Molinaro, S Hervey-Jumper, RA Morshed… - JAMA …, 2020 - jamanetwork.com
Importance Per the World Health Organization 2016 integrative classification, newly
diagnosed glioblastomas are separated into isocitrate dehydrogenase gene 1 or 2 (IDH) …

Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis

TJ Brown, MC Brennan, M Li, EW Church… - JAMA …, 2016 - jamanetwork.com
Importance Glioblastoma multiforme (GBM) remains almost invariably fatal despite optimal
surgical and medical therapy. The association between the extent of tumor resection (EOR) …

5-ALA and FDA approval for glioma surgery

CG Hadjipanayis, W Stummer - Journal of neuro-oncology, 2019 - Springer
Abstract The US Food and Drug Administration (FDA) approved 5-aminolevulinic acid (5-
ALA; Gleolan®; photonamic GmbH and Co. KG) for use as an intraoperative optical imaging …

Current and future strategies for treatment of glioma

NAO Bush, SM Chang, MS Berger - Neurosurgical review, 2017 - Springer
Gliomas are one of the most common types of primary brain tumors and have remained
particularly challenging to treat. This review illustrates a multidisciplinary approach to the …

[HTML][HTML] Modified criteria for radiographic response assessment in glioblastoma clinical trials

BM Ellingson, PY Wen, TF Cloughesy - Neurotherapeutics, 2017 - Elsevier
Radiographic endpoints including response and progression are important for the
evaluation of new glioblastoma therapies. The current RANO criteria was developed to …

Beyond the margins: real-time detection of cancer using targeted fluorophores

RR Zhang, AB Schroeder, JJ Grudzinski… - Nature reviews Clinical …, 2017 - nature.com
Over the past two decades, synergistic innovations in imaging technology have resulted in a
revolution in which a range of biomedical applications are now benefiting from fluorescence …

Maximizing safe resection of low-and high-grade glioma

SL Hervey-Jumper, MS Berger - Journal of neuro-oncology, 2016 - Springer
Surgical resection plays a central role in the management of gliomas. In this study, we
review the evidence in support of extent of resection to improve survival, symptom …